These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 15142400)

  • 21. Findings from the observational COMPLY study in children and adolescents with ADHD: core symptoms, ADHD-related difficulties, and patients' emotional expression during psychostimulant or nonstimulant ADHD treatment.
    Dittmann RW; Banaschewski T; Schacht A; Wehmeier PM
    Atten Defic Hyperact Disord; 2014 Dec; 6(4):291-302. PubMed ID: 24705867
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Glutamatergic changes with treatment in attention deficit hyperactivity disorder: a preliminary case series.
    Carrey N; MacMaster FP; Sparkes SJ; Khan SC; Kusumakar V
    J Child Adolesc Psychopharmacol; 2002; 12(4):331-6. PubMed ID: 12625993
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A post hoc subgroup analysis of an 18-day randomized controlled trial comparing the tolerability and efficacy of mixed amphetamine salts extended release and atomoxetine in school-age girls with attention-deficit/hyperactivity disorder.
    Biederman J; Wigal SB; Spencer TJ; McGough JJ; Mays DA
    Clin Ther; 2006 Feb; 28(2):280-93. PubMed ID: 16678649
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Attention-deficit/hyperactivity disorder: etiology and pharmacotherapy.
    Noorbala AA; Akhondzadeh S
    Arch Iran Med; 2006 Oct; 9(4):374-80. PubMed ID: 17061613
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment stabilization in children and adolescents with attention-deficit/hyperactivity disorder: data from the Netherlands.
    Sasané R; Hodgkins P; Meijer W
    Curr Med Res Opin; 2010 Nov; 26(11):2565-74. PubMed ID: 20863165
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacotherapy of attention-deficit hyperactivity disorder in children and adolescents: update on new stimulant preparations, atomoxetine, and novel treatments.
    Prince JB
    Child Adolesc Psychiatr Clin N Am; 2006 Jan; 15(1):13-50. PubMed ID: 16321724
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The practice and problem of therapeutic agents for AD/HD].
    Tanaka H; Miyajima T
    No To Hattatsu; 2010 May; 42(3):213-6. PubMed ID: 23858580
    [No Abstract]   [Full Text] [Related]  

  • 28. [Drugs for attention deficit hyperactivity disorder].
    Montañés-Rada F; Gangoso-Fermoso AB; Martíínez-Granero MA
    Rev Neurol; 2009 May 1-15; 48(9):469-81. PubMed ID: 19396764
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacotherapy with atomoxetine for US children and adolescents.
    Bhatara VS; Aparasu RR
    Ann Clin Psychiatry; 2007; 19(3):175-80. PubMed ID: 17729019
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Changes and challenges: managing ADHD in a fast-paced world.
    Manos MJ; Tom-Revzon C; Bukstein OG; Crismon ML
    J Manag Care Pharm; 2007 Nov; 13(9 Suppl B):S2-S13; quiz S14-S16. PubMed ID: 18062734
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Injury prevention by medication among children with attention-deficit/hyperactivity disorder: a case-only study.
    Mikolajczyk R; Horn J; Schmedt N; Langner I; Lindemann C; Garbe E
    JAMA Pediatr; 2015 Apr; 169(4):391-5. PubMed ID: 25686215
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Update on Current Care guidelines: ADHD (attention-deficit/hyperactivity disorder, children and adolescents)].
    Käypä hoito suosituksen päivitystiivistelmä
    Duodecim; 2012; 128(5):539-40. PubMed ID: 22486070
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Atomoxetine and methylphenidate treatment in children with ADHD: a prospective, randomized, open-label trial.
    Kratochvil CJ; Heiligenstein JH; Dittmann R; Spencer TJ; Biederman J; Wernicke J; Newcorn JH; Casat C; Milton D; Michelson D
    J Am Acad Child Adolesc Psychiatry; 2002 Jul; 41(7):776-84. PubMed ID: 12108801
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Attention-deficit/hyperactivity disorder among children and adolescents in the United States: trend in diagnosis and use of pharmacotherapy by gender.
    Sclar DA; Robison LM; Bowen KA; Schmidt JM; Castillo LV; Oganov AM
    Clin Pediatr (Phila); 2012 Jun; 51(6):584-9. PubMed ID: 22399571
    [No Abstract]   [Full Text] [Related]  

  • 35. Multicenter, randomized, open-label study of OROS methylphenidate versus atomoxetine: treatment outcomes in African-American children with ADHD.
    Starr HL; Kemner J
    J Natl Med Assoc; 2005 Oct; 97(10 Suppl):11S-16S. PubMed ID: 16350601
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Core ADHD symptom improvement with atomoxetine versus methylphenidate: a direct comparison meta-analysis.
    Hazell PL; Kohn MR; Dickson R; Walton RJ; Granger RE; Wyk GW
    J Atten Disord; 2011 Nov; 15(8):674-83. PubMed ID: 20837981
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Methylphenidate and atomoxetine for treatment of nocturnal enuresis in a child with attention-deficit hyperactivity disorder.
    Bahali K; Ipek H; Uneri OS
    Eur Child Adolesc Psychiatry; 2013 Oct; 22(10):649-50. PubMed ID: 23553575
    [No Abstract]   [Full Text] [Related]  

  • 38. Atomoxetine hydrochloride and executive function in children with attention-deficit/hyperactivity disorder.
    Barton J; Mooney P; Prasad S
    J Child Adolesc Psychopharmacol; 2005 Apr; 15(2):147-9. PubMed ID: 15910196
    [No Abstract]   [Full Text] [Related]  

  • 39. Non-stimulant trials of adult ADHD.
    Adler LA
    CNS Spectr; 2007 Apr; 12(4 Suppl 6):11-3. PubMed ID: 17717871
    [No Abstract]   [Full Text] [Related]  

  • 40. [Attention-deficit/hyperactivity disorder (ADHS) in adulthood].
    Kordon A; Kahl KG
    Psychother Psychosom Med Psychol; 2004; 54(3-4):124-36. PubMed ID: 15037976
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.